These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11375740)

  • 21. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes.
    Mikov M; Đanić M; Pavlović N; Stanimirov B; Goločorbin-Kon S; Stankov K; Al-Salami H
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):881-890. PubMed ID: 28534261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of pulsed ultrafiltration-mass spectrometry.
    Johnson BM; Nikolic D; van Breemen RB
    Mass Spectrom Rev; 2002; 21(2):76-86. PubMed ID: 12373745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.
    Fisher MB; Henne KR; Boer J
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):101-9. PubMed ID: 16445122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.
    White RE
    Annu Rev Pharmacol Toxicol; 2000; 40():133-57. PubMed ID: 10836130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting drug pharmacokinetics in humans from in vitro metabolism studies.
    McGinnity DF; Riley RJ
    Biochem Soc Trans; 2001 May; 29(Pt 2):135-9. PubMed ID: 11356141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origin and evolution of high throughput screening.
    Pereira DA; Williams JA
    Br J Pharmacol; 2007 Sep; 152(1):53-61. PubMed ID: 17603542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolving role of drug metabolism in drug discovery and development.
    Yengi LG; Leung L; Kao J
    Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The pharmacokinetic process: is the drug getting to its site of action?: Drug metabolism].
    Carrillo Norte JA
    Rev Enferm; 2011; 34(7-8):52-60. PubMed ID: 21919387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
    Szymański P; Markowicz M; Mikiciuk-Olasik E
    Int J Mol Sci; 2012; 13(1):427-52. PubMed ID: 22312262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolite identification in drug discovery.
    Watt AP; Mortishire-Smith RJ; Gerhard U; Thomas SR
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):57-65. PubMed ID: 12613277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
    Bhoopathy S; Xin B; Unger SE; Karnes HT
    J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates.
    Drexler DM; Belcastro JV; Dickinson KE; Edinger KJ; Hnatyshyn SY; Josephs JL; Langish RA; McNaney CA; Santone KS; Shipkova PA; Tymiak AA; Zvyaga TA; Sanders M
    Assay Drug Dev Technol; 2007 Apr; 5(2):247-64. PubMed ID: 17477833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.